Dow Up 0.25% Nasdaq Up 0.65%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
3.35 Up 0.01(0.30%) May 27, 3:59PM EDT
Prev Close:3.34
Open:3.30
Bid:3.35 x 5800
Ask:3.37 x 200
1y Target Est:16.50
Beta:0.620152
Earnings Date:Aug 9 - Aug 15 (Est.)
Day's Range:3.30 - 3.37
52wk Range:3.05 - 10.85
Volume:4,444
Avg Vol (3m):19,033
Market Cap:30.37M
P/E (ttm):N/A
EPS (ttm):-1.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABIO

Comparison

Symbol% ChgMkt Cap
ABIOUp 0.30%30.37M
AZNDown 0.23%75.60B
GSKDown 0.79%103.84B
ILIUDown 5.41%24.22M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback